Get started
Author

Yumiko Sakai

Observed name: 酒井, 由美子
Institution: Sysmex (Japan)
ORCID: 0000-0003-2657-7716
Observed ORCID: 0000-0003-2657-7716
OpenAlex ID: A5110166018
A novel in vitro system, the integrated discrete multiple organ cell culture (IdMOC) system, for the evaluation of human drug toxicity: comparative cytotoxicity of tamoxifen towards normal human cells from five major organs and MCF-7 adenocarcinoma breast cancer cells
2004 · Albert P. Li, Chris Bode, et al. · Chemico-Biological Interactions · 112
Applications of microarrays with toxicologically relevant genes (tox genes) for the evaluation of chemical toxicants in Sprague Dawley rats in vivo and human hepatocytes in vitro
2004 · Larry D Kier, Robin Neft, et al. · Mutation research. Fundamental and molecular mechanisms of mutagenesis · 110
Flavocetin-A and -B, two high molecular mass glycoprotein Ib binding proteins with high affinity purified fromTrimeresurus flavoviridis venom, inhibit platelet aggregation at high shear stress
1995 · Yuta Taniuchi, Tomihisa Kawasaki, et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 67
Differential in vitro hepatotoxicity of troglitazone and rosiglitazone among cryopreserved human hepatocytes from 37 donors
2002 · Scott Lloyd, Michael J Hayden, et al. · Chemico-Biological Interactions · 47
Comparative Studies of an Orally-active Factor Xa Inhibitor, YM-60828, with other Antithrombotic Agents in a Rat Model of Arterial Thrombosis
1998 · Kazuo Sato, Yumiko Sakai, et al. · Thrombosis and Haemostasis · 41
Correlation between troglitazone cytotoxicity and drug metabolic enzyme activities in cryopreserved human hepatocytes
2002 · Nicola J Hewitt, Scott Lloyd, et al. · Chemico-Biological Interactions · 31
Effect of bupropion on CYP2B6 and CYP3A4 catalytic activity, immunoreactive protein and mRNA levels in primary human hepatocytes: comparison with rifampicin
2003 · Leah M Hesse, Yumiko Sakai, et al. · Journal of Pharmacy and Pharmacology · 28
Antiplatelet and Antithrombotic Effects of YM337, the Fab Fragment of a Humanized Anti-GPIIb/IIIa Monoclonal Antibody in Monkeys
1996 · Seiji Kaku, Tomihisa Kawasaki, et al. · Thrombosis and Haemostasis · 17
Isolation and Amino Acid Sequence of Flavostatin, a Novel Disintegrin From the Venom of Trimeresurus flavoviridis
1997 · Kazunori Maruyama, Tomihisa Kawasaki, et al. · Peptides · 15
A novel automated immunoassay for serum NY-ESO-1 and XAGE1 antibodies in combinatory prediction of response to anti-programmed cell death-1 therapy in non-small-cell lung cancer
2021 · Yumiko Sakai, Koji Kurose, et al. · Clinica Chimica Acta · 13
PDF
Comparison of the antiplatelet effect of YM337 and abciximab in rhesus monkeys
1997 · Ken-ichi Suzuki, Yumiko Sakai, et al. · European Journal of Pharmacology · 11
Antithrombotic effect of a humanized anti-GPIIb/IIIa monoclonal antibody, YM207, in a photochemically induced thrombosis model in monkeys
1995 · Seiji Kaku, Tomihisa Kawasaki, et al. · European Journal of Pharmacology · 10
Highly sensitive and non-disruptive detection of residual undifferentiated cells by measuring miRNAs in culture supernatant
2022 · Kanako Masumoto, Yuki Aihara, et al. · Scientific Reports · 9
PDF
Comparison of the antiplatelet agent potential of the whole molecule, F(ab)2 and fab fragments of humanized anti-GPIIb/IIIa monoclonal antibody in monkeys
1996 · Seiji Kaku, Shinya Yano, et al. · General Pharmacology The Vascular System · 5
Immune checkpoint therapy and response biomarkers in non-small-cell lung cancer: Serum NY-ESO-1 and XAGE1 antibody as predictive and monitoring markers
2022 · Koji Kurose, Kanako Sakaeda, et al. · Advances in clinical chemistry · 4
Morphological and Molecular Characterization of Menstrual Blood Cellular Components
2026 · Margarita Artemenko, Yumiko Sakai, et al. · Reproductive Medicine · 2
PDF
Automated immunoassay of serum NY-ESO-1 and XAGE1 antibodies for predicting clinical benefit with immune checkpoint inhibitor (ICI) in advanced non-small cell lung cancer
2024 · Kanako Sakaeda, Koji Kurose, et al. · Cancer Treatment and Research Communications · 2
Effect of bupropion on CYP2B6 and CYP3A4 catalytic activity, immunoreactive protein and mRNA levels in primary human hepatocytes: comparison with rifampicin
2003 · Leah M Hesse, Yumiko Sakai, et al. · Journal of Pharmacy and Pharmacology · 2
PDF
Thrombolytic activity of YM866, a novel modified tissue‐type plasminogen activator, in a rabbit model of jugular vein thrombosis
1994 · Tomihisa Kawasaki, Seiji Kaku, et al. · Drug Development Research · 2
Synergistic effect of aurintricarboxylic acid and triflavin in a photochemically induced thrombosis model in rats
1996 · Nami Hisamichi, Tomihisa Kawasaki, et al. · European Journal of Pharmacology · 1
Wcn26-2907 High-sensitivity Anti-nephrin Autoantibody Assay Predicts Steroid Resistance and Glomerulonephritis in Childhood Idiopathic Nephrotic Syndrome
2026 · Tomoko Horinouchi, Masaya Muto, et al. · Kidney International Reports
PDF
Wcn26-2384 a Novel Automated Immunoassay for Anti-nephrin Autoantibodies Using a Mutant Nephrin Antigen
2026 · Masaya Muto, Tomoko Horinouchi, et al. · Kidney International Reports
Abstract A61: Development of automated immunoassay to detect serum biomarkers predicting response to immune checkpoint inhibitors in NSCLC
2022 · Kanako Sakaeda, Koji Kurose, et al. · Cancer Immunology Research
Abstract 3180: Development of a fully automated immunoassay system for detection of serum NY-ESO-1 and XAGE1 antibodies as biomarkers predicting the clinical efficacy of anti-PD-1 therapy
2020 · Yumiko Sakai, Hirotaka Abo, et al. · Cancer Research
口腔内出血症状から確認された第ⅷ因子インヒビターの１症例
2012 · 山崎, 明, 山田, 隆, et al. · Institutional Repositories DataBase (IRDB)
PDF
Works count: 26
Citation count: 529
H-index: 11
I10-index: 12
Year
Topic
Type